Receive instant notifications when news about your stocks is posted. Request your 1-week free trial at StreetInsider Premium here.
MONTREAL, March 01, 2021 (GLOBE...
The CAB will lead and advise Genprex as it advances its REQORSA immunogen therapy program, including its Acclaim clinical trials in non-small cell lung...